Company / Capital Expenditures
Oric Pharmaceuticals, Inc. Capital Expenditures History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$712.0K
FY2025
5-year range
$712.0K / $2.1M
FY2021-FY2025
Trend
-40.1%
vs FY2024
Sector context
#127 of 194
Health Care
What the data says
At $712,000, Oric Pharmaceuticals, Inc.'s capital expenditures ranks #127 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 8 years, ranging from $525,000 in FY2018 to $2M in FY2022.
Based on SEC 10-K filings.
$712,000 in FY2025 with a 5-year CAGR of +1.3%.
Declined from $849,000 to $712,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -30.0%
- 5-Year CAGR
- +1.3%
- 10-Year CAGR
- -
Sector benchmark
#127 of 194 in Health CareTop 65% of 194This company $712.0K Sector average $117.5M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.3%, indicating consistent growth.
- In FY2025, capital expenditures decreased 40.1% year-over-year.
- Ranks #127 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $712.0K | -40.1% |
| FY2024 | $1.2M | +39.9% |
| FY2023 | $849.0K | -59.1% |
| FY2022 | $2.1M | +121.3% |
| FY2021 | $939.0K | +40.8% |
| FY2020 | $667.0K | -13.2% |
| FY2019 | $768.0K | +46.3% |
| FY2018 | $525.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026